Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.08 (overall 0.05) | 0.08 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 64 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 5340
Sealed predictions
- ZRANB3 in dopamine neurons, braak+0.75 (p 0.019) → +0.62 (p 0.073)receipt 5348
Swarm cases
receipt 5348: ZRANB3 in dopamine neurons, braak
- power
- full sample +0.67 (p 0.0024, n 18), 95% CI +0.29 to +0.87. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.76 (p 2.4e-4, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.76 (p 2.4e-4, n 18). not the mix.
- skeptic
- leave-one-out range +0.62 to +0.75, sign flips 0; without severely affected donors +0.67 (p 0.0024, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZRANB3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts